data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Metacrine
(NASDAQ:MTCR)
$0.4761
-0.0238[-4.76%]
At close: Jul 1
$0.4744
-0.0017[-0.36%]
After Hours: 7:28PM EDT
Day High/Low0.47 - 0.5
52 Week High/Low0.35 - 4.12
Open / Close0.47 / 0.48
Float / Outstanding39.4M / 42.5M
Vol / Avg.171.2K / 897.7K
Mkt Cap20.2M
P/E-
50d Avg. Price0.46
Div / Yield-
Payout Ratio-
EPS-0.31
Total Float39.4M

Metacrine (NASDAQ:MTCR), Quotes and News Summary

Metacrine (NASDAQ: MTCR)

Day High/Low0.47 - 0.5
52 Week High/Low0.35 - 4.12
Open / Close0.47 / 0.48
Float / Outstanding39.4M / 42.5M
Vol / Avg.171.2K / 897.7K
Mkt Cap20.2M
P/E-
50d Avg. Price0.46
Div / Yield-
Payout Ratio-
EPS-0.31
Total Float39.4M
Benzinga - May 12, 2022, 5:34PM
Benzinga - May 12, 2022, 4:26PM
Benzinga - Mar 30, 2022, 4:13PM
Benzinga - Feb 24, 2022, 5:30PM
Benzinga - Feb 11, 2022, 11:55AM
Benzinga - Feb 11, 2022, 8:08AM
Benzinga - Feb 11, 2022, 8:07AM
Benzinga - Feb 11, 2022, 8:07AM
Benzinga - Feb 1, 2022, 2:04PM
Benzinga - Dec 27, 2021, 10:41AM
Benzinga - Dec 27, 2021, 8:08AM
Benzinga - Dec 17, 2021, 3:42PM
Benzinga - Nov 11, 2021, 8:06AM
Benzinga - Nov 2, 2021, 11:25AM
Benzinga - Nov 2, 2021, 8:04AM
Benzinga - Oct 22, 2021, 12:10PM
load more
Sector: Health Care.Industry: Biotechnology
Metacrine Inc is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases. Its program targets the farnesoid X receptor, or FXR, which is central to modulating liver and GI diseases. Its FXR product candidates include MET409 and MET642.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.390-0.310 0.0800
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Metacrine Questions & Answers

Q
How do I buy Metacrine (MTCR) stock?
A

You can purchase shares of Metacrine (NASDAQ: MTCR) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Metacrine's (MTCR) competitors?
Q
What is the target price for Metacrine (MTCR) stock?
A

The latest price target for Metacrine (NASDAQ: MTCR) was reported by Canaccord Genuity on Friday, October 22, 2021. The analyst firm set a price target for 1.00 expecting MTCR to rise to within 12 months (a possible 110.04% upside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Metacrine (MTCR)?
A

The stock price for Metacrine (NASDAQ: MTCR) is $0.4761 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Metacrine (MTCR) pay a dividend?
A

There are no upcoming dividends for Metacrine.

Q
When is Metacrine (NASDAQ:MTCR) reporting earnings?
A

Metacrine’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Metacrine (MTCR) going to split?
A

There is no upcoming split for Metacrine.

Q
What sector and industry does Metacrine (MTCR) operate in?
A

Metacrine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.